VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 223 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,508 | -46.5% | 4,102 | -39.1% | 0.00% | -40.0% |
| Q1 2024 | $68,267 | +128.5% | 6,739 | +126.9% | 0.01% | +66.7% |
| Q4 2023 | $29,879 | +302.1% | 2,970 | +274.5% | 0.00% | +200.0% |
| Q3 2023 | $7,431 | -49.6% | 793 | +31.9% | 0.00% | 0.0% |
| Q2 2023 | $14,743 | -67.6% | 601 | -69.3% | 0.00% | -80.0% |
| Q1 2023 | $45,563 | +224.4% | 1,958 | +252.8% | 0.01% | +150.0% |
| Q4 2022 | $14,047 | -26.1% | 555 | -42.8% | 0.00% | -33.3% |
| Q3 2022 | $19,000 | +90.0% | 970 | +145.6% | 0.00% | +200.0% |
| Q2 2022 | $10,000 | +400.0% | 395 | +456.3% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 71 | +115.2% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 33 | -52.2% | 0.00% | – |
| Q3 2021 | $3,000 | – | 69 | +1280.0% | 0.00% | – |
| Q2 2021 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |